The 5th International Conference on Fibroblast Growth Factors Held in Wenzhou an
2018-10-30
Longtime found in Authorized Patent
Establish in
2003
Patent applied
82
Founded in 2003, Nanhai Longtime Pharmaceutical Co., Ltd. is the industrialization base of the national first-class new drug “ recombinant human basic fibroblast growth factor(rh-bFGF)”. rh-bFGF is clinically used for the treatment of trauma, surgical wounds, burns and ulcers, etc., producing significant therapeutic effects. It is a first-line medication recommended by Clinical Guideline. Over the years, it has won many national awards, such as the Second Prize of National Award for Technological Invention and the First Prize of National Science and Technology Progress Award.
News Center
2018-10-30
2018-09-11
On September 7, 2018, Biotechnology Innovation and Development Summit in Guangdong-Hong Kong-Macao Greater Bay Area...
more
2018-01-27
OnJanuary 22, 2018, Nanhai Longtime Pharmaceutical Co., Ltd. held a grand openingceremony for Guangdong Cell Growth...
more
2016-07-27
On July 12, 2016, the Turkish delegation arrived at Nanhai Longtime Pharmaceutical Co., Ltd. on schedule to condu...
more
Products
Achieve Users And Create Value
Guangdong Province Research and development of cell growth factors Engineering technology Research Center
2018 year Guangdong Province "abide by the contract and honor" enterprise
Chinese Society for Bioengineering Industry Promotion association bio-pharmaceutical industry base
National Ministry of Education Genomic Drug Project Research Center (South China Sea) pilot test base
China Biomedical Cosmetology Professional Committee Biological beauty products (South China Sea) testing center
Peking University Thousand Cell Center Laboratory (South China Sea) pilot test base